| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.009 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |